On Tuesday, Syndax Pharmaceuticals Inc (NASDAQ: SNDX) was 0.05% up from the session before settling in for the closing price of $20.96. A 52-week range for SNDX has been $11.22 – $25.34.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 1801.91% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at -29.68%. With a float of $80.62 million, this company’s outstanding shares have now reached $84.83 million.
In an organization with 184 employees, it is important to assess its efficiency.
Syndax Pharmaceuticals Inc (SNDX) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Syndax Pharmaceuticals Inc stocks. The insider ownership of Syndax Pharmaceuticals Inc is 5.11%, while institutional ownership is 100.47%. The most recent insider transaction that took place on Aug 09 ’23, was worth 965,402. In this transaction Director of this company sold 52,855 shares at a rate of $18.27, taking the stock ownership to the 17,836 shares. Before that another transaction happened on Aug 02 ’23, when Company’s Director sold 83,000 for $20.46, making the entire transaction worth $1,697,810. This insider now owns 48,000 shares in total.
Syndax Pharmaceuticals Inc (SNDX) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -29.68% per share during the next fiscal year.
Syndax Pharmaceuticals Inc (NASDAQ: SNDX) Trading Performance Indicators
You can see what Syndax Pharmaceuticals Inc (SNDX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 10.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.96, a number that is poised to hit -0.99 in the next quarter and is forecasted to reach -2.90 in one year’s time.
Technical Analysis of Syndax Pharmaceuticals Inc (SNDX)
Let’s dig in a bit further. During the last 5-days, its volume was 1.1 million. That was inferior than the volume of 1.15 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 24.69%. Additionally, its Average True Range was 0.89.
During the past 100 days, Syndax Pharmaceuticals Inc’s (SNDX) raw stochastic average was set at 56.86%, which indicates a significant increase from 16.31% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 31.99% in the past 14 days, which was lower than the 49.04% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $22.71, while its 200-day Moving Average is $19.06. However, in the short run, Syndax Pharmaceuticals Inc’s stock first resistance to watch stands at $21.37. Second resistance stands at $21.77. The third major resistance level sits at $22.00. If the price goes on to break the first support level at $20.74, it is likely to go to the next support level at $20.51. The third support level lies at $20.11 if the price breaches the second support level.
Syndax Pharmaceuticals Inc (NASDAQ: SNDX) Key Stats
There are 84,965K outstanding shares of the company, which has a market capitalization of 1.78 billion. As of now, sales total 0 K while income totals -209,360 K. Its latest quarter income was 0 K while its last quarter net income were -72,470 K.
